We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

134 hedge funds and large institutions have $787M invested in Arena Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 134 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less call options, than puts

Call options by funds: $68.6M | Put options by funds: $80.9M

Holders
134
Holders Change
+134
Holders Change %
–
% of All Funds
4.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
134
Increased
–
Reduced
–
Closed
–
Calls
$68.6M
Puts
$80.9M
Net Calls
-$12.3M
Net Calls Change
-$12.3M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$1.06M +$1.12M +13,763 New
BA
52
BlackRock Advisors
Delaware
$1.01M +$1.07M +13,065 New
LPL Financial
53
LPL Financial
California
$877K +$930K +11,395 New
PA
54
Profund Advisors
Maryland
$848K +$899K +11,010 New
RA
55
Rational Advisors
New York
$809K +$857K +10,500 New
T. Rowe Price Associates
56
T. Rowe Price Associates
Maryland
$752K +$798K +9,770 New
N
57
Nuveen
North Carolina
$729K +$773K +9,469 New
Macquarie Group
58
Macquarie Group
Australia
$677K +$717K +8,789 New
CBOA
59
Commonwealth Bank of Australia
Australia
$660K +$699K +8,567 New
RFC
60
Russell Frank Company
Washington
$635K +$623K +7,630 New
UBS AM
61
UBS AM
Illinois
$629K +$668K +8,181 New
Zurich Cantonal Bank
62
Zurich Cantonal Bank
Switzerland
$616K +$653K +8,000 New
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$616K +$653K +7,999 New
Arrowstreet Capital
64
Arrowstreet Capital
Massachusetts
$602K +$638K +7,816 New
SGAM
65
Smith Group Asset Management
Texas
$590K +$626K +7,667 New
Millennium Management
66
Millennium Management
New York
$581K +$616K +7,550 New
RJFSA
67
Raymond James Financial Services Advisors
Florida
$519K +$551K +6,745 New
Citigroup
68
Citigroup
New York
$516K +$547K +6,703 New
NTCOC
69
Northern Trust Company of Connecticut
Connecticut
$505K +$536K +6,564 New
USAA
70
United Services Automobile Association
Texas
$496K +$526K +6,440 New
Cambridge Investment Research Advisors
71
Cambridge Investment Research Advisors
Iowa
$494K +$524K +6,417 New
LWM
72
Lyons Wealth Management
Florida
$478K +$504K +6,178 New
Principal Financial Group
73
Principal Financial Group
Iowa
$456K +$484K +5,923 New
NPC
74
National Planning Corporation
California
$436K +$458K +5,610 New
AG
75
Aperio Group
California
$395K +$419K +5,131 New
1 2
3
4 5

ARNA Hedge Fund Activity: Q2 2013 in Review

134 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2013, worth a combined $787M.

Buyers outnumbered sellers: 134 funds opened new ARNA positions and 0 closed out — a net gain of 134 holders — while 0 added to existing stakes and 0 trimmed.

  • 134 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $787M of Arena Pharmaceuticals Inc stock for Q2 2013.
  • 134 funds opened new Arena Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +134 holders.

Based on aggregated 13F filings for Q2 2013.